<DOC>
	<DOCNO>NCT01437865</DOCNO>
	<brief_summary>The aim pilot-study examine accuracy gadofosveset enhance MRI compare current nodal staging method . The accuracy MRL determine basis node-to-node match imaged node definitive histopathology . The pathologic examination SNLB ALND regard golden standard nodal involvement .</brief_summary>
	<brief_title>Gadofosveset Axillary Staging Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Patient histopathologically confirm invasive breast cancer undergo nodal stag . 2 . Tumor must T2 accord TNM 6classification . 3 . The ultrasound axilla must suspect nodal metastasis . 4 . Willing able undergo study procedures 5 . Has personally provide write informed consent . 1 . Age &lt; 18 2 . History prior chemotherapy 3 . History prior radiotherapy surround area axilla . 4 . Pregnancy 5 . Contra indication MRI pacemaker , aneurysm clip severe claustrophobia . 6 . Allergy ingredient Gadofosveset ( Vasovist® /Ablavar® ) 7 . Being unable give inform consent person 8 . Acute chronic severe renal insufficiency ( glomerular filtration rate &lt; 30 mL/min/1.73m2 ) . 9 . Acute renal insufficiency severity due hepatorenal syndrome perioperative liver transplantation period .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>MRI</keyword>
	<keyword>lymph node metastasis</keyword>
	<keyword>breast cancer</keyword>
	<keyword>gadofosveset</keyword>
</DOC>